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B
 
oth T cell tolerance and productive T cell responses
require the interaction of the TCR with specific
MHC–peptide ligands, triggering a cascade of signals that
ultimately can lead to either proliferation or cell death (1–
3). These two opposing processes, which can occur during
both peripheral T cell activation and/or positive/negative
selection of T cells in the thymus, seem to be tuned by two
different mechanisms: either by the strength of avidity/af-
finity of the TCR for their ligands, or by the differential
changes in the conformation or orientation of the TCR af-
ter its ligation on the MHC–peptide complexes (4, 5). Re-
cently, the outcomes of T cell activation in periphery or of
thymic selection have been related to the agonist or antag-
onist activity of MHC peptide ligands for the TCR; the
agonist ligands, having high affinity for the TCR (slow dis-
sociation), would promote deletion in the thymus and full
activation in the periphery; the antagonist ligands, having
low affinity for the TCR (rapid dissociation), would have
the opposite effects (6). Analysis of the intracellular events
in T cells in response to antagonist/partial agonist ligands
reported distinct patterns of 
 
z
 
 chain phosphorylation fol-
lowed by a failure to activate the ZAP-70 kinase (7, 8).
Costimulatory molecules were also shown to play a crucial
role in the signaling events, e.g., interactions between B7.1
or B7.2 and CD28, or CD40 and CD40L can provide co-
stimulatory signals for T cell priming in periphery or for
deletion during intrathymic T cell development (9, 10). In
this context, several experimental models suggest that toler-
ance of self-reactive T cells can only be established to those
self determinants that are generated in sufficient amounts
during processing to be recognized by T cells undergoing
deletion in the thymus or anergy in the periphery (11). In-
deed, there is ample evidence that self-reactive T cells es-
caping from thymic tolerance exist in the peripheral T cell
pool of healthy individuals or experimental animals (12).
This may occur if the self determinants are not expressed in
the thymus, e.g. if they are cryptic, because they are not
generated, or they are generated at subthreshold levels for
acting as T cell epitopes (11, 13, 14). T cells specific for
these epitopes are present in the normal repertoire in igno-
rance, but might be activated and become dangerous if the
cryptic epitopes are made “visible” to the immune system
(13–16). A critical question is how self epitopes that are
normally cryptic can influence positive selection of specific
T cells in the thymus and can elicit autoreactive T cells in
periphery sustaining pathogenetic responses. Different mecha-
nisms have been proposed, particularly for explaining how
cryptic epitopes can be unveiled on the one hand, and how
ignorant autoreactive T cells can be awakened in periphery
on the other hand (11–16).
A report in this issue of 
 
The Journal of Experimental Medi-
cine
 
 strongly supports the idea that molecular mimicry
could account for the activation and clonal expansion of
autoreactive T cells (17). Previous studies combining single
amino acid substitution analysis at TCR contact residues of
a self peptide, together with the knowledge that amino acid
side chains required for binding to MHC are degenerate
(18), led to the identification of T cell stimulatory ligands
derived from microbial proteins (19). Notably, the identi-
fied epitopes did not share sequence homologies with the
autoantigen in positions other than TCR. This type of ap-
proach is, however, impaired by the large number of indi-
vidual peptides necessary to define a single T cell epitope.
The paper by Hemmer et al. describes the use of com-
pletely random combinatorial peptide libraries to identify
multiple cross-reactive ligands for an autoreactive T cell
clone specific for peptide 86–96 of the myelin basic protein
(MBP). The combinatorial peptide library approach that
has recently been used to define the structural basis for
MHC class II–restricted peptide presentation (20) has emerged
as an extremely powerful way to determine which amino
acid sequence interacts with a particular protein. In the
Hemmer et al. study (17), the authors have analyzed the re-
sponse of the MBP-specific clone to 220 11-mer peptide
sublibraries. Based on the results obtained with the peptide
libraries for each amino acid position of the peptide se-
quence, novel peptides were found that induced prolifera-
tive response at much lower concentrations than original
MBP peptide. The analysis of these sequences by protein
database search led to the identification of cross-reactive
peptides derived from self and microbial proteins; some of
them were more potent agonists than the MBP peptide for
T cell activation. From these data, the authors conclude
that for at least some autoreactive T cells, antigen recogni-
tion is highly degenerate. The elegant work by Hemmer et
al. is reminiscent of results of Nanda et al. (21), suggesting
that some TCR, as well as polyspecific Ig, could have a
multisite structure capable of being stimulated by a large
panel of peptides associated with a given MHC molecule.
Altogether, these evidences could shed a new light on old
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data demonstrating that virtually all antigen-specific T cells
are degenerate since they are capable of recognizing differ-
ent allelic forms of MHC–peptide complexes (22). The re-
cently solved three-dimensional structure of a human TCR–
MHC–peptide complex provides a structural basis for the
limited specificity of the TCR (23, 24). The peptide is
bound very deeply in the MHC molecule, thus providing
only a few atoms of peptide residues for the contact with
the TCR (24).
An interesting point discussed by Hemmer et al. (17) is
that since the MBP-specific T cell clone proliferates to 
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 g/ml for each single peptide, a concentration far be-
low the concentration of the best hypothetical T cell
epitope, it is plausible to envisage that the library contains a
high number of different ligands that are stimulatory for the
T cell clone. In reality, however, the degeneracy of T cell
recognition may be less frequent than expected. Indeed,
only a few of these sequences will be generated from natu-
ral proteins, and even fewer will be generated during anti-
gen processing. Moreover, with regard to the self epitopes
generated and presented by APCs, they seem to be no
more than a few thousand (25, 26). Thus, the possibility
that a degenerated TCR on a given T cell can be triggered
by multiple self epitopes presented on the thymic APCs is
expected to be exceptional.
A number of studies have demonstrated that although
the recognition by the TCR is rather flexible in that more
than one type of peptide can induce a response, the quality
of the T cell response evoked by such so-called altered
peptide ligands (APLs) can be very different (27). Hemmer
et al. (17) only consider those peptides with agonist func-
tion resulting in cross-reactive responses by the MBP(86-
96)–specific T cell clone. It is reasonable to assume that the
response by the same clone could be dramatically different
in response to APLs, which should be equally represented
either in peptide libraries used by the Martin’s group (17),
or among peptides presented by APCs in vivo. Some of the
APLs could induce different stimulatory functions, whereas
others could switch off the T cell activation and thus influ-
ence the establishment of positive/negative selection in the
thymus or of clonal activation, partial activation, or anergy
in periphery.
In conclusion, the findings reported by Hemmer et al., as
well as that by other laboratories (17, 19), have important
implications for the pathogenesis of autoimmune disease
because they establish an important link between immune
responses to infectious agents and autoimmunity. With re-
spect to the mechanisms by which the molecular mimicry
at the T cell level could lead to disease, the following sce-
nario could be envisaged. Although the number of self
peptides presented by living cells is much more restricted
than that shown with artificial peptide repertoires, negative
or positive selection in the thymus for those T cells having
a high degree of TCR degeneracy may be determined by
the quality of the stimulation which results in the recogni-
tion of the different ligands presented by thymic APCs (27,
28). Thus, in addition to known parameters, such as the af-
finity/avidity of TCR for MHC–peptide complexes, the
stability of the MHC–peptide complexes and the kinetics
of TCR–MHC–peptide interaction, the degeneracy of an-
tigen recognition by TCR seems to play a major role in in-
fluencing T cell selection. In particular, thymocytes engag-
ing multiple agonist ligands will undergo negative selection
(low off-rate interaction). In contrast, T cells triggered by a
larger amount of different APLs, which could overwhelm
the function of agonist peptides simultaneously present on
APCs, will be positively selected, and therefore, will be-
come part of the peripheral T cell pool (high off-rate inter-
action). Hemmer et al. suggest that these cells presumably
would remain harmless in the periphery in case they en-
counter the same self peptides which positively selected the
T cells in the thymus (17). It is tempting to hypothesize
that if a peripheral T cell is fully activated by a given micro-
bial epitope, the pool of cross-reactive self peptides, if act-
ing as APLs, could switch off T cell activation. This mech-
anism could be advantageous for controlling autoimmunity,
but disadvantageous for clearing those pathogens which
have not been promptly eliminated during the early phases
of the infections. Alternatively, a more adverse picture
could be depicted: the T cell, activated by a microbial pep-
tide, could also cross-react with multiple agonist self epitopes
which, being cryptic, have not induced negative selection
in the thymus, thus leading to priming and the establish-
ment of autoimmune processes. This, however, should be a
remote possibility in view of the different “protective” mech-
anisms that can take place. (
 
a
 
) Self epitopes are generally se-
questered in privileged organs and are thus inaccessible to
the immune system, or are cryptic because they are not gener-
ated or generated in insufficient amounts during constitutive
processing by APCs. This means that they have to be un-
veiled, for instance, by inflammatory processes after viral infec-
tions to be efficiently processed and presented by profes-
sional APCs (14). (
 
b
 
) Cryptic epitopes may be presented by
nonprofessional APCs, such as resting B cells or epithelial
cells, which could tolerize the autoreactive T cells (29). (
 
c
 
)
The cross-reactive self epitopes, once unveiled, will not neces-
sarily behave as agonists, but may act either as an antagonist
or as a partial agonist for TCR, leading to either death, an-
ergy, or a change in the T cell function (27). These mecha-
nisms could account for the limited occurrence of autoim-
mune phenomena despite the TCR degeneracy.
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